Q-and-A: Focus on the "underappreciated" aids growth

05/14/2007 | NYTimes.com

Becton, Dickinson & Co. makes 25 billion needles a year; its CEO says that the company is in "the middle of the food chain in terms of technical sophistication" and that much of the company's growth comes from applying technology to "underappreciated" health problems. Edward J. Ludwig, who also serves as chairman of AdvaMed, also said, "Making the right acquisitions has become more and more challenging."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY